NCT05873660View on ClinicalTrials.gov

A Study to Characterize the Prevalence of Overweight and Obesity Among Patients With Established Cardiovascular Disease

CompletedOBSERVATIONAL
Enrollment

5,360

Participants

Timeline

Start Date

June 12, 2023

Primary Completion Date

June 24, 2024

Study Completion Date

June 24, 2024

Conditions
ObesityOverweight
Interventions
OTHER

No treatment given

No treatment given

Trial Locations (5)

08536

Novo Nordisk Investigational Site, Plainsboro

Unknown

Novo Nordisk Investigational Site, São Paulo

Novo Nordisk Investigational Site, Ontario

Novo Nordisk Investigational Site, Riyadh

Novo Nordisk Investigational Site, Madrid

Sponsors

Lead Sponsor

Novo Nordisk A/S
All Listed Sponsors
lead

Novo Nordisk A/S

INDUSTRY

NCT05873660 - A Study to Characterize the Prevalence of Overweight and Obesity Among Patients With Established Cardiovascular Disease | Biotech Hunter | Biotech Hunter